Literature DB >> 12655344

Hepatitis C virus biology.

C Giannini1, C Bréchot.   

Abstract

Hepatitis C virus infection represents a major problem of public health with around 350 millions of chronically infected individuals worldwide. The frequent evolution towards severe liver disease and cancer are the main features of HCV chronic infection. Antiviral therapies, mainly based on the combination of IFN and ribavirin can only assure a long term eradication of the virus in less than half of treated patients. The mechanisms underlying HCV pathogenesis and persistence in the host are still largely unknown and the efforts made by researchers in the understanding the viral biology have been hampered by the absence of a reliable in vitro and in vivo system reproducing HCV infection. The present review will mainly focus on viral pathogenetic mechanisms based on the interaction of HCV proteins (especially core, NS3 and NS5A) with host cellular signaling transduction pathways regulating cell growth and viability and on the strategies developed by the virus to persist in the host and escape to antiviral therapy. Past and recent data obtained in this field with different experimental approaches will be discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12655344     DOI: 10.1038/sj.cdd.4401121

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  70 in total

1.  Membrane binding properties and terminal residues of the mature hepatitis C virus capsid protein in insect cells.

Authors:  Tomoaki Ogino; Hiroyuki Fukuda; Shinobu Imajoh-Ohmi; Michinori Kohara; Akio Nomoto
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane.

Authors:  Christophe Hourioux; Malika Ait-Goughoulte; Romuald Patient; Delphine Fouquenet; Fabienne Arcanger-Doudet; Denys Brand; Annette Martin; Philippe Roingeard
Journal:  Cell Microbiol       Date:  2006-12-06       Impact factor: 3.715

Review 3.  New therapeutic opportunities for hepatitis C based on small RNA.

Authors:  Qiu-Wei Pan; Scot D Henry; Bob J Scholte; Hugo W Tilanus; Harry L A Janssen; Luc J W van der Laan
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

4.  Hepatitis B and hepatitis C virus replication upregulates serine protease inhibitor Kazal, resulting in cellular resistance to serine protease-dependent apoptosis.

Authors:  Jason Lamontagne; Mark Pinkerton; Timothy M Block; Xuanyong Lu
Journal:  J Virol       Date:  2009-10-28       Impact factor: 5.103

5.  Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features.

Authors:  Steeve Boulant; Christophe Vanbelle; Christine Ebel; François Penin; Jean-Pierre Lavergne
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Lucidone suppresses hepatitis C virus replication by Nrf2-mediated heme oxygenase-1 induction.

Authors:  Wei-Chun Chen; Sheng-Yang Wang; Chien-Chih Chiu; Chin-Kai Tseng; Chun-Kuang Lin; Hui-Chun Wang; Jin-Ching Lee
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

7.  Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif.

Authors:  Björn Schwer; Shaotang Ren; Thomas Pietschmann; Jürgen Kartenbeck; Katrin Kaehlcke; Ralf Bartenschlager; T S Benedict Yen; Melanie Ott
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

8.  Characterization of hepatitis C virus core protein multimerization and membrane envelopment: revelation of a cascade of core-membrane interactions.

Authors:  Li-Shuang Ai; Yu-Wen Lee; Steve S-L Chen
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

9.  Kinetic analysis of the nucleic acid chaperone activity of the hepatitis C virus core protein.

Authors:  Kamal kant Sharma; Pascal Didier; Jean Luc Darlix; Hugues de Rocquigny; Hayet Bensikaddour; Jean-Pierre Lavergne; François Pénin; Jean-Marc Lessinger; Yves Mély
Journal:  Nucleic Acids Res       Date:  2010-02-18       Impact factor: 16.971

10.  Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen.

Authors:  Ekaterina Alekseeva; Irina Sominskaya; Dace Skrastina; Irina Egorova; Elizaveta Starodubova; Eriks Kushners; Marija Mihailova; Natalia Petrakova; Ruta Bruvere; Tatyana Kozlovskaya; Maria Isaguliants; Paul Pumpens
Journal:  Genet Vaccines Ther       Date:  2009-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.